Moderna Inc (MRNA) earnings · rev $1.94B
These earnings events as JSON? API free 100/dayModerna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
This MRNA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
When the next MRNA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 39.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MRNA research stays on the stock page; the tape stays on the quote page.
MRNA earnings FAQ
What are MRNA's latest revenue and net income?
Latest cached Moderna Inc (MRNA) revenue for Dec 31, 2025 was $1.94B. Net income was -$2.82B. Statements: https://lician.com/financials/mrna
What is MRNA's latest diluted EPS?
Latest cached Moderna Inc (MRNA) diluted EPS for Dec 31, 2025 was -$7.26.
What period does the latest MRNA earnings print cover?
The latest cached Moderna Inc (MRNA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MRNA revenue change from the prior cached period?
Cached Moderna Inc (MRNA) revenue was down 39.9% from $3.24B (Dec 31, 2024) to $1.94B (Dec 31, 2025). Statements: https://lician.com/financials/mrna
Where are MRNA earnings listed?
Cached earnings facts for Moderna Inc (MRNA) are listed at https://lician.com/earnings/mrna. Statements: https://lician.com/financials/mrna
Not investment advice.